Numbers put us in the know. We saw that with COVID-19, and now again, with Rwanda snuffing out the Marburg virus outbreak in ...
A new study has revealed that daily oral antiretrovirals, like Truvada, are highly effective at preventing HIV when taken consistently alongside regular medical check-ups but their efficacy ...
The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
This drug helps manage infections and prevent AIDS, but claims it’s a ‘cure’ are not supported
"Currently, there is no therapeutic cure for HIV," Sheryl Zwerski, who holds a Doctor of Nursing Practice and directs the Prevention Sciences Program at the National Institute of Allergy and ...
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
More than 5,000 people diagnosed with HIV each year in Argentina, with 98% of all infections a result of unprotected sex.
J.P. Morgan analyst Chris Schott has maintained their bullish stance on GILD stock, giving a Buy rating yesterday.Pick the best stocks and ...
Gilead Sciences (GILD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Courtney ...
Lenacapavir is an injection given to women every six months, which has proven to protect women, especially those at high risk of contracting the HIV virus. Dr. Flavia revealed that during their study ...
The incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir compared with daily oral emtricitabine-tenofovir disoproxil fumarate.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback